Updates are available Correction dated 2019-01-10

Article History

First Online: 7 December 2018

Change Date: 10 January 2019

Change Type: Correction

Change Details: Page 7, Table 1, ASN002 row. The cell entry in column 4, “Manufacturer”, which previously read:

Compliance with Ethical Standards

:

: EG-Y is an employee of Mount Sinai and has received research funds (grants paid to the institution) from Abbvie, Celgene, Galderma, Glenmark, Janssen Biotech, LEO Pharmaceuticals, Novartis, Pfizer, Regeneron, Asana, DS Biopharma, Innovvaderm, Ralexar, and Novan. She receives consulting fees/honorarium from AbbVie, Celgene, Dermira, Galderma, Glenmark, Novartis, Pfizer, Regeneron, Sanofi, Mitsubishi Tanabe, Eli Lilly, Asana, Kyowa Kirin, Allergan, DS Bipharma, and Concert. She serves on the advisory board for Celgene, Dermira, Galderma, Glenmark, LEO Pharma, Novartis, Pfizer, Sanofi, Regeneron, Eli Lilly, Asana, Kyowa Kirin, Allergan, DBV, Escalier, and Dermavant. HH has no conflict of interest.

: No funds were received for preparation of this review.